Morning Market Losers

Celsus Therapeutics Plc CLTX shares dropped 81.36% to $1.15 on failed Phase 2 MRX-6 cream trial. Vascular Biogenics Ltd.VBLT shares dipped 55.28% to $6.31 after the company announced the removal of the FDA partial clinical hold on VB-111. VBL Therapeutics announced its plans to discontinue the development of VB-201 in ulcerative colitis and psoriasis following Phase 2 results. Helix Energy Solutions Group, Inc. HLX shares slipped 13.36% to $16.53 after the company reported downbeat Q4 results. Vanguard Natural Resources, LLC VNR shares dropped 9.18% to $16.43 after the company reported Q4 preliminary adjusted profit of $0.19 per unit, versus analysts' estimates of $0.26 per unit. The company also lowered its January distribution from $0.21 to $0.1175 per unit. CoStar Group Inc. CSGP shares declined 7.15% to $186.19 after the company issued a weak Q1 and FY15 earnings guidance. Agios Pharmaceuticals, Inc. AGIO fell 6.86% to $110.42 following wider than expected quarterly loss. Walter Energy, Inc. WLT shares dropped 4.50% to $1.04 after the company reported a wider-than-expected Q4 loss. Macy's, Inc.M shares declined 1.90% to $63.10. Analysts at Barclays initiated coverage on Macy's with a Underweight rating.